<--- Back to Details
First PageDocument Content
Pharmaceutical industry / Dow Jones Industrial Average / Pharmacy / Mylan / King Pharmaceuticals / Pfizer / Johnson & Johnson / Barr Pharmaceuticals / Ivax Corporation / Pharmaceutical sciences / Pharmaceuticals policy / Pharmacology
Date: 2013-01-31 21:59:02
Pharmaceutical industry
Dow Jones Industrial Average
Pharmacy
Mylan
King Pharmaceuticals
Pfizer
Johnson & Johnson
Barr Pharmaceuticals
Ivax Corporation
Pharmaceutical sciences
Pharmaceuticals policy
Pharmacology

Microsoft Word - 394459_1.DOC

Add to Reading List

Source URL: ag.hawaii.gov

Download Document from Source Website

File Size: 140,47 KB

Share Document on Facebook

Similar Documents

M&A and Contested Solicitation Assignments  © 2016 D.F. King & Co., Inc. | Confidential – Not For Distribution Mergers •

M&A and Contested Solicitation Assignments © 2016 D.F. King & Co., Inc. | Confidential – Not For Distribution Mergers •

DocID: 1oYLi - View Document

2010 PATENTLY-O PATENT LAW JOURNAL An Initial Comment on King Pharmaceuticals: The Printed Matter Doctrine as a Structural Doctrine and Its Implications for Prometheus Laboratories1 By Kevin Emerson Collins2

2010 PATENTLY-O PATENT LAW JOURNAL An Initial Comment on King Pharmaceuticals: The Printed Matter Doctrine as a Structural Doctrine and Its Implications for Prometheus Laboratories1 By Kevin Emerson Collins2

DocID: 1kS08 - View Document

Microsoft PowerPoint - Luncheon - Ruben King-Shaw v.2

Microsoft PowerPoint - Luncheon - Ruben King-Shaw v.2

DocID: 14BXi - View Document

Venture Capital Funding Quarterly Biotechnology • Pharmaceuticals Medical Devices 4th Quarter, 2013 – North America Publisher VentureDeal

Venture Capital Funding Quarterly Biotechnology • Pharmaceuticals Medical Devices 4th Quarter, 2013 – North America Publisher VentureDeal

DocID: RQPt - View Document

Venture Capital Funding Quarterly Biotechnology • Pharmaceuticals Medical Devices 3rd Quarter, 2014 – North America Publisher VentureDeal

Venture Capital Funding Quarterly Biotechnology • Pharmaceuticals Medical Devices 3rd Quarter, 2014 – North America Publisher VentureDeal

DocID: ROga - View Document